Fonar Corp (NASDAQ: FONR)

FONAR Corporation, with its ticker symbol FONR, operates in the medical equipment industry, specifically focusing on the design, manufacturing, selling, and servicing of magnetic resonance imaging (MRI) scanners. Founded in 1978, FONAR has established itself as a pioneer in the MRI scanner market, offering a unique product line that provides diagnostic advantages over traditional MRI scanners.

FONAR's primary business activity is the medical equipment segment, which is conducted directly through the company. This segment is dedicated to the design, manufacture, and sale of MRI scanners. FONAR's flagship product is the Upright MRI scanner, a whole-body MRI scanner that can be used to scan virtually any part of the body. This scanner is unique in that it can scan patients in a variety of postures, including sitting, standing, bending, or lying down, as opposed to traditional MRI scanners that limit patients to the recumbent posture.

In the MRI scanner market, FONAR competes with industry giants such as Siemens, General Electric, Hitachi, Philips, Canon, and United Imaging. While these competitors primarily focus on the high-field (1.0 T and above) marketplace, FONAR's Upright MRI scanner offers a unique and unmatched proposition.

FONAR's products are classified as Class II devices by the FDA, subject to general controls such as establishment registration, medical device listing, manufacturing in accordance with the Current Good Manufacturing Practices Quality System Regulation, labeling in accordance with labeling regulations, and submission of a Premarket Notification (510(k)) before marketing. The company has received FDA clearance for its Upright MRI scanner and has established written procedures for the implementation of the Medical Device Reporting regulation.

In terms of marketing, FONAR targets four primary audiences: neurosurgeons, orthopedic surgeons, radiologists, and general physicians. The company uses internal personnel and independent manufacturer's representatives for domestic and foreign sales. FONAR's marketing strategy has been successful, leading to many inquiries and some sales of the Upright MRI scanner.

In addition to the medical equipment segment, FONAR operates the physician management and diagnostic services segment through its subsidiary, Health Management Corporation of America (HMCA). HMCA provides comprehensive non-medical management services to diagnostic imaging facilities, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing, IT services, hiring, conducting interviews and managing personnel, storage of medical records, office space, equipment, repair, maintenance service, and clerical and other non-medical personnel. HMCA's clients receive reimbursements for their services through Medicare, Medicaid, managed care, private commercial insurance, third-party administrators, Workers' Compensation, and No-Fault insurance.

FONAR's research and development activities have been successful in enhancing the capabilities of its MRI scanners and improving their diagnostic capabilities. During the fiscal year ended June 30, 2023, FONAR incurred expenditures of $1,567,749 on research and development, focusing primarily on software improvements to the user interface of the MRI scanner.